Pharmaceutical solution of amlodipine

US11723866B2 · kind B2 · utility

Assignee

• Liqmeds Worldwide Limited · GB

Inventors

• Jayanta Kumar MANDAL · Ahmedabad, IN
• Malay PATEL · Cochranville, US
• Swati NAGAR · Amreli, IN
• Michael Paul DeHart · Winterville, US

Key dates

• Filing date: Jun 15, 2022
• Grant date: Aug 15, 2023
• Expiry date: Jun 15, 2042

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein is a liquid pharmaceutical formulation substantially free of water, comprising: (i) amlodipine or a pharmaceutically acceptable salt thereof, (ii) at least one pharmaceutically acceptable excipient, and (iii) a sufficient amount of a vehicle comprising glycerin. Also disclosed herein is a liquid pharmaceutical formulation substantially free of water and ethanol, comprising: (i) amlodipine or a pharmaceutically acceptable salt thereof, (ii) at least one pharmaceutically acceptable excipient, and (iii) a sufficient amount of a vehicle comprising glycerin.